Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

Susan S. Jacobs(Stanford University), Jerry A. Krishnan(University of Illinois Chicago), David J. Lederer(Regeneron (United States)), Marya Ghazipura(New York University Florence), Tanzib Hossain(New York University Florence), Ai-Yui M. Tan(University of Illinois Chicago), Brian Carlin(Hematology Oncology Consultants), Michael Drummond, Magnus Ekström, Chris Garvey(University of California, San Francisco), Bridget A. Graney(University of Colorado System), Beverly Jackson, Thomas J Kallstrom, Shandra L. Knight(National Jewish Health), Kathleen O. Lindell(University of Pittsburgh), Valentin Prieto-Centurion(University of Illinois Chicago), Elisabetta Renzoni(Royal Brompton Hospital), Christopher J. Ryerson(University of British Columbia), Ann Schneidman, Jeffrey J. Swigris(National Jewish Health), Dona Upson, Anne E. Holland(Monash University)
American Journal of Respiratory and Critical Care Medicine
November 1, 2020
Cited by 295Open Access
Full Text

Abstract

Abstract Background Evidence-based guidelines are needed for effective delivery of home oxygen therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Methods The multidisciplinary panel created six research questions using a modified Delphi approach. A systematic review of the literature was completed, and the Grading of Recommendations Assessment, Development and Evaluation approach was used to formulate clinical recommendations. Recommendations The panel found varying quality and availability of evidence and made the following judgments: 1) strong recommendations for long-term oxygen use in patients with COPD (moderate-quality evidence) or ILD (low-quality evidence) with severe chronic resting hypoxemia, 2) a conditional recommendation against long-term oxygen use in patients with COPD with moderate chronic resting hypoxemia, 3) conditional recommendations for ambulatory oxygen use in patients with COPD (low-quality evidence) or ILD (low-quality evidence) with severe exertional hypoxemia, 4) a conditional recommendation for ambulatory liquid-oxygen use in patients who are mobile outside the home and require >3 L/min of continuous-flow oxygen during exertion (very-low-quality evidence), and 5) a recommendation that patients and their caregivers receive education on oxygen equipment and safety (best-practice statement). Conclusions These guidelines provide the basis for evidence-based use of home oxygen therapy in adults with COPD or ILD but also highlight the need for additional research to guide clinical practice.


Related Papers

No related papers found

Powered by citation graph analysis